Cytogenetics and Molecular Genetics of Malignant Gliomas and Medulloblastoma

Brain Pathology

Volumn 1, Issue 1, 1990, Pages 12-18

  Bigner, Sandra H ^a   Vogelstein, Bert ^b  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ANEUPLOIDY; BRAIN TUMOR; CELL TRANSFORMATION; CHILD; CHROMOSOME ABERRATION; FEMALE; GENE AMPLIFICATION; GENE DELETION; GENETIC MARKER; GENETICS; GLIOMA; HUMAN; KARYOTYPING; MALE; MEDULLOBLASTOMA; PATHOLOGY; PROTO ONCOGENE; REVIEW; TUMOR SUPPRESSOR GENE;

ADULT; ANEUPLOIDY; BRAIN NEOPLASMS; CELL TRANSFORMATION, NEOPLASTIC; CHILD; CHROMOSOME ABERRATIONS; FEMALE; GENE AMPLIFICATION; GENE DELETION; GENES, TUMOR SUPPRESSOR; GENETIC MARKERS; GLIOMA; HUMAN; KARYOTYPING; MALE; MEDULLOBLASTOMA; PROTO-ONCOGENES;

EID: 0025478315     PISSN: 10156305     EISSN: 17503639     Source Type: Journal    
DOI: 10.1111/j.1750-3639.1990.tb00633.x     Document Type: Conference Paper

References (50)

1. Phenotypic analysis of four human medulloblas‐toma cell line and transplantable xenografts
2. Primitive neuroectodermal tumors of the central nervous system express neuroendocrine markers and may express all classes of intermediate filaments
3. Revision of the World Health Organization classification of brain tumors for childhood brain tumors
4. Minute chromatin bodies in malignant tumours of childhood
5. Phenotypic and genotypic analysis a human medulloblastoma cell line and transplantable xenograft (D‐341 Med) demonstrating amplification of c‐myc
6. N‐myc amplification and neuronal differentiation in human primitive neuroectodermal tumors of the central nervous system
7. Amplification of the C‐MYC gene in medulloblastoma cell lines and xenografts
8. Oncogene amplification in pediatric brain tumors
9. Cytogenetic studies of human brain tumors and their clinical significance. I. Medulloblastoma
10. Structural chromosomal abnormalities in human medulloblastoma
11. Chromosome abnormalities in pediatric brain tumors
12. A der(11)t(8;11) in two medulloblastomas: A possible nonrandom cytogenetic abnormality
13. Isochromosome 17q in primitive neuroectodermal tumors of the central nervous system
14. Chromosomal characteristics of neurogenic tumours in adults
15. Cytogenetic studies in twenty human brain tumors: Association of No. 22 chromosome abnormalities with tumors of the brain
16. Chromosomal patterns in human malignant astrocytomas
17. Specific chromosomal abnormalities in malignant human gliomas
18. A cytogenetic study of 53 human gliomas
19. Trisomy 7 and sex chromosome loss in human brain tissue
20. Clonal genomic alterations in glioma malignancy stages
21. Loss of heterozygosity on chromosome 10 in human glioblastoma multiforme
22. Mitotic recombination of chromosome 17 in astrocytomas
23. Loss of heterozygosity for loci on chromosome 17p in human malignant astrocytoma
24. Loss of distinct regions on the short arm of chromosome 17 associated with tumorigenesis of human astrocytomas
25. Mutations in the p53 gene occur in diverse tumor types
26. Prevalence of ras gene mutations in human colorectal cancers
27. Identification by fluorescence of the G chromosome lost in human meningiomas
28. Cytological and cytogenetical studies on brain tumors. IV. Identification of the missing G chromosomes in human meningiomas as No. 22 by fluorescenc technique
29. Deletion mapping of a locus on human chromosome 22 involved in the oncogenesis of meningioma
30. Molecular genetic approach to human meningioma: Loss of genes on chromosome 22
31. Loss of genes on chromosome 22 in tumorigenesis of human acoustic neuroma
32. Common pathogenetic mechanism for three tumor types in bilateral acoustic neurofibromatosis
33. Genetic linkage of bilateral acoustic neurofibromatosis to a DNA marker on chromosome 22
34. Amplification, enhanced expression and possible rearrangement of EGF receptor gene in primary human brain tumors of glial origin
35. Increased expression of the EGF receptor gene in malignant gliomas is invariably associated with gene amplification
36. Relationship between gene amplification and chromosomal deviations in malignant human gliomas
37. Identification of an amplified, highly expressed gene in a malignant glioma
38. The Gli gene is a member of the kruppel family of zinc finger proteins
39. Evidence for rearrangement, amplification, and expression of c‐myc in a human glioblastoma
40. Gene amplification in malignant human gliomas: Clinical and histopathologic aspects
41. Amplification and expression of the epidermal growth factor receptor gene in human glioma xenografts
42. Amplification of the structurally and functionally altered epidermal growth factor receptor gene (c‐erbB) in human brain tumors
43. Selective amplification of the cytoplasmic domain of the epidermal growth factor receptor gene in glioblastoma multiforme
44. Anti‐synthetic peptide antibody reacting at the fusion junction of deletion‐mutant epidermal growth factor receptors in human glioblastoma
45. Amplified, overexpressed and rearranged epidermal growth factor receptor gene in a human astrocytomas cell line
46. Amplified gene for the epidermal growth factor receptor in a human glioblastoma cell line encodes an enzymatically inactive protein
47. Loss of epidermal growth factor receptor gene amplification as malignant human gliomas establish in culture
48. Expression of messenger RNAs for platelet‐derived growth factor and transforming growth factor‐alpha and their receptors in human malignant glioma cell lines
49. Genetic alterations during colorectal tumor development
50. Many gene changes found in cancer